A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma [Protocol 11-085] |
Segal, Neil |
|
A Phase I Study of MED14736 in Patients with Advanced Solid Tumors [Protocol 12-179] |
Segal, Neil |
|
A Phase I Study of BMS-986015 plus BMS-936558 in Patients with Advanced Solid Tumors [Protocol 12-224] |
Segal, Neil |
- Colorectal Cancer
- Kidney Cancer
- Lung Cancer, Non-Small Cell
- Melanoma
- Ovarian Cancer
|
A Phase I Study of IMMU-130 in Patients with Colorectal Cancer [Protocol 11-074] |
Segal, Neil |
|
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases [Protocol 12-046] |
Seidman, Andrew |
- Brain Tumors, Metastatic
- Breast Cancer
|
A Phase II Study of Concurrent Intensity-Modulated Radiation Therapy (IMRT),
Paclitaxel, and Pazopanib/Placebo for the Treatment of Anaplastic Thyroid Cancer [Protocol 10-186] |
Sherman, Eric |
|
A Phase II Study of Dasatinib in Children and Adolescents Newly Diagnosed with Chronic Phase CML or with Philadelphia Chromosome-Positive Leukemias Resistant to or Intolerant of Imatinib [Protocol 11-030] |
Shukla, Neerav |
- Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myelocytic Leukemia
|
Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia [Protocol 11-002] |
Shukla, Neerav |
- Leukemia
- Acute Lymphoblastic Leukemia
|
ALTE03N1: Key Adverse Events Following Childhood Cancer [Protocol 05-070] |
Sklar, Charles |
|
Adoptive Transfer of Autologous T Cells Targeted to Prostate-Specific Membrane Antigen for the Treatment Of Castrate Metastatic Prostate Cancer [Protocol 09-036] |
Slovin, Susan |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of AT13387 Alone or with Abiraterone to Treat Castration-Resistant Prostate Cancer that Continues Growing Despite Abiraterone [Protocol 12-248] |
Slovin, Susan |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
Examination of Tissue from Ablated Malignant Liver Metastases to Predict Outcome [Protocol 09-122] |
Sofocleous, Constantinos |
- Colorectal Cancer
- Hepatobiliary
- Liver Metastases
|
Evaluation of Freezing Kidney Cancer Followed by Confirmation with Biopsy or Resection [Protocol 09-108] |
Solomon, Stephen |
|
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy [Protocol 11-011] |
Souweidane, Mark |
|
Evaluating the Causes of Cancer in Young Patients [Protocol 09-068] |
Stadler, Zsofia |
- Breast Cancer
- Colorectal Cancer
- Colon Cancer
- Rectal Cancer
- Germ Cell Tumors
- Hereditary Cancer & Genetics
- Neuroblastoma
- Primary Bone
- Sarcomas
|
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients [Protocol 04-144] |
Stadler, Zsofia |
- Colorectal Cancer
- Hereditary Cancer & Genetics
- Psychiatry & Behavioral Sciences
|
A Phase I Study of BI 836858 in Patients with Relapsed or Refractory Acute Myeloid Leukemia [Protocol 12-133] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I Study of Tigecycline in Patients with Relapsed or Refractory Acute Myeloid Leukemia [Protocol 12-148] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I Study of EPZ-5676 in Patients with Relapsed/Refractory Leukemia and Other Advanced Hematologic Cancers [Protocol 12-181] |
Tallman, Martin |
- Hematology
- Hematologic Malignancies
- Myelodysplastic Syndrome
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Neoplasm
|
A Phase I/II Study of Eltrombopag During Consolidation Therapy in Adults with Acute Myeloid Leukemia in Complete Remission [Protocol 12-229] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|